Abstract:Macrophages host Leishmania major infection, which causes cutaneous Leishmaniasis in humans. In the murine model, resistance to infection depends on the host immunity mediated by CD4 T-cell cytokines and macrophages. In association to other stimuli, the Th1 cytokine IFN-γ induces NO-mediated microbial killing by M1/classically-activated macrophages. By contrast, the Th2 cytokine IL-4 promotes M2/alternatively activated macrophages, which express arginase-1 and shelter infection. Other cytokines, such as RANKL, might also participate in the crosstalk between T cells and macrophages to restrict parasite infection. RANKL and its receptor RANK are known to play an essential role in bone remodeling, by inducing osteoclatogenesis. It has also been shown that RANKL stimulates antigen-presenting cells, such as DCs and macrophages, to enhance T cell responses. Here we investigated how RANKL directly modulates the effector macrophage phenotypes and immunity to L. major parasites. We found that inflammatory peritoneal macrophages from B6 mice express RANK and M2 features, such as CD301 (MGL) and CD206 (mannose receptor). Nonetheless, treatment with RANKL or IFN-γ induced macrophage differentiation into more mature F40/80hi macrophages able to produce IL-12 and TNF-α. In parallel, macrophages treated with RANKL, IFN-γ, or RANKL along with IFN-γ progressively downregulated the expression of the M2 hallmarks MGL, arginase-1, and CCL17. Moreover, a synergism between IFN-γ and RANKL enhanced inducible NO synthase (iNOS) expression and NO production by macrophages. These results are consistent with the idea that RANKL helps IFN-γ to induce a M2-like to M1 phenotype shift. Accordingly, concomitant treatment with RANKL and IFN-γ promoted macrophage-mediated immunity to L. major, by inducing NO and ROS-dependent parasite killing. Furthermore, by cooperating with IFN-γ, endogenous RANKL engages CD4 T-cell help toward L. major-infected macrophages to upregulate M1 and Th1 cytokine responses. Therefore, RANKL, in combination with IFN-γ, is a potential local therapeutic tool to improve immune responses in Leishmaniasis, by skewing M2-like into effector M1 macrophages.

Leishmania major- derived lipophosphoglycan influences the host's early immune response by inducing platelet activation and DKK1 production via TLR1/2

The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts

Leishmania donovani-Induced Prostaglandin E2 Generation Is Critically Dependent on Host Toll-Like Receptor 2-Cytosolic Phospholipase A2 Signaling

Activation Pathways of Murine Macrophages by Lipophosphoglycan from Strains of Leishmania major (FV1 and LV39)

Differential structure and immunomodulatory functions of lipophosphoglycan between Leishmania spp

TLR11 or TLR12 silencing reduces Leishmania major infection

RANK Ligand Helps Immunity to Leishmania major by Skewing M2-Like Into M1 Macrophages

NLRP1-dependent activation of Gasdermin D in neutrophils controls cutaneous leishmaniasis

Pathogen-associated molecular patterns (PAMPs) derived from Leishmania and bacteria increase gene expression of antimicrobial peptides and gut surface proteins in sand flies

HIF-alpha signaling mediates the macrophage inflammatory response during Leishmania major infection

TLR2 dimer‐specific ligands selectively activate protein kinase C isoforms in Leishmania infection

Using machine learning to dissect host kinases required for Leishmania internalization and development

HIF-α signaling regulates the macrophage inflammatory response during Leishmania major infection

Leishmania infection-derived extracellular vesicles drive transcription of genes involved in M2 polarization

Vaccination with Leishmania mexicana LPG induces PD-1 in CD8+ and PD-L2 in macrophages thereby suppressing the immune response: A model to assess vaccine efficacy

MAPK/ERK activation in macrophages promotes Leishmania internalization and pathogenesis

LmjF.36.3850, a novel hypothetical Leishmania major protein, contributes to the infection

The role of CD4+ T cells in visceral leishmaniasis; new and emerging roles for NKG7 and TGFβ

Ly6G deficiency alters the dynamics of neutrophil recruitment and pathogen capture during Leishmania major skin infection

Leishmania amazonensis infection impairs dendritic cell migration from the inflammatory site to the draining lymph node

Macrophage-derived developmental endothelial locus 1 (DEL-1) expression promotes an immunoprotective phenotype in experimental visceral leishmaniasis